This may have something to do with why they are ramping up the indiana site:
Positron Recieves Radioactive Materials License from Nuclear
Share Business ExchangeTwitterFacebook| Email | Print | A A A
Positron Recieves Radioactive Materials License from Nuclear Regulatory
Commission
Business Wire
INDIANAPOLIS -- March 01, 2010
Positron Corporation (OTCBB:POSC) a molecular imaging solutions company
focused on Nuclear Cardiology, announced today that the Nuclear Regulatory
Commission has licensed the Positron facility in Fishers, Indiana to handle
radioactive material. Positron Corporation and staff demonstrated the
necessary expertise and protocol to receive this license. A radioactive
material handling license allows Positron to test equipment and develop new
technologies, including pharmaceuticals. “A radioactive material license
directly benefits our current product line and increases our ability to
deliver new technologies,” stated John A. Zehner, Positron Corporation, COO
and Radiation Safety Officer. “The ability to handle radioactive material will
enhance our sales efforts, allow new revenue streams, as well as, offer new
opportunities to partner with pharmaceutical companies, Government agencies,
inventors and universities.”
About Positron: Positron founded in 1983, is a molecular imaging company
focused on Nuclear Cardiology. Positron utilizes its proprietary product line
to provide unique solutions to the Nuclear Medicine community ranging from
imaging systems to radiopharmaceutical distribution. Positron products
include: the Attrius™, a PET imaging device; the Pulse®, a SPECT imaging
device; the Nuclear Pharm-Assist®, an automated radiopharmaceutical
distribution device; and the Tech-Assist™, a radiopharmaceutical injection
shield. Positron is headquartered in Indianapolis, Indiana. More information
about Positron is available at www.positron.com.
Forward Looking Statements: Statements in this document contain certain
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended. These
statements are based on many assumptions and estimates and are not guarantees
of future performance and may involve known and unknown risks, uncertainties
and other factors which may cause the actual results, performance or
achievements of Positron Corporation to be materially different from future
results, performance or achievements expressed or implied by such
forward-looking statements. Our actual results may differ materially from the
results anticipated in these forward-looking statements due to a variety of
factors, including, without limitation those set forth as "Risk Factors" in
our filings with the Securities and Exchange Commission.
For further information please contact Positron Corporation at (317) 576-0183.
Contact:
Positron Corporation
John Zehner
(317) 576-0183
Last Updated: March 1, 2010 13:46 EST
The Altruis PET scanner is manufactured by Neusoft in China through the JV. The Nuclear Pharm Assist is manufactured here in in the US in Indiana through the accusition of Dose Shield Corp (Acquisitions was completed last year July/August 2009). Positron is ready to launch the Cardio-Assist Device - a"virtual compound pharmacy" in the physicians offices. The Cardio Assist will also be manufactured at their Indiana Site.
